Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Amanda Tamman, Amit Anand & Sanjay J. Mathew. (2022) A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression. Expert Opinion on Drug Safety 21:6, pages 745-759.
Read now
Read now
Articles from other publishers (4)
C. Reif-Leonhard, A. Reif, B. T. Baune & E. Kavakbasi. (2022) Vagusnervstimulation bei schwer zu behandelnden DepressionenVagus nerve stimulation for difficult to treat depression. Der Nervenarzt 93:9, pages 921-930.
Crossref
Crossref
Christoph Kraus, Darin Quach, David M. Sholtes, Erhan Kavakbasi, Renske De Zwaef, Maxine Dibué, John Zajecka & Bernhard T. Baune. (2022) Setting Up a Successful Vagus Nerve Stimulation Service for Patients With Difficult-to-Treat Depression. Neuromodulation: Technology at the Neural Interface 25:3, pages 316-326.
Crossref
Crossref
Mark S. George, Kevin A. Caulfield & Melanie Wiley. 2022. Neuroplasticity - From Bench to Bedside. Neuroplasticity - From Bench to Bedside
497
507
.
Alpana Singh, Ted M. Dawson & Subhash Kulkarni. (2021) Neurodegenerative disorders and gut-brain interactions. Journal of Clinical Investigation 131:13.
Crossref
Crossref